Recruiting Determining the Prevalence of Muir-Torre Syndrome in Patients With Lynch Syndrome NCT07201012 Conditions Basal Cell Carcinoma of Skin, Site Unspecified, Carcinoma, Carcinoma, Basal Cell, +32 more Locations CHU de Nîmes — Nîmes, Gard, France View Trial Details
Active, Not Recruiting Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers NCT02978625 Conditions Adenocarcinoma, Adenocarcinoma, Papillary, Anaplastic Large Cell Lymphoma, ALK-Positive, +86 more Locations Los Angeles General Medical Center — Los Angeles, California, United States USC / Norris Comprehensive Cancer Center — Los Angeles, California, United States UC Irvine Health/Chao Family Comprehensive Cancer Center — Orange, California, United States Keck Medical Center of USC Pasadena — Pasadena, California, United States View all 36 locations View more locations Show fewer locations Loading locations... View Trial Details
